NFKB1 and pancreatitis: Our studies indicate that the small chemical PKD suppressors possess significant potential as therapeutic intervention to alleviate/prevent serious pancreatitis at early stage of the disease or to prevent recurrent pancreatitis through suppressing NF-κB activation.